We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$6.91B
AUM Growth
+$82.5M
Cap. Flow
-$567M
Cap. Flow %
-8.2%
Top 10 Hldgs %
24.12%
Holding
865
New
42
Increased
270
Reduced
470
Closed
20

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$34.6M
2
WMT icon
Walmart Inc
WMT
+$12.2M
3
NVDA icon
NVIDIA
NVDA
+$8.11M
4
EOLS icon
Evolus
EOLS
+$7.02M
5
ABBV icon
AbbVie
ABBV
+$6.93M

Sector Composition

Rank Sector Weight
1 Technology 23.46%
2 Financials 11.35%
3 Healthcare 9.92%
4 Industrials 8.66%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQLT icon
776
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
$255K ﹤0.01%
5,892
GDX icon
777
VanEck Gold Miners ETF
GDX
$23.2B
$253K ﹤0.01%
4,865
-100
-2% -$4.96K
IWY icon
778
iShares Russell Top 200 Growth ETF
IWY
$15.7B
$252K ﹤0.01%
1,023
ADM icon
779
Archer Daniels Midland
ADM
$40.1B
$252K ﹤0.01%
4,765
-462
-9% -$22.5K
NUTX
780
Nutex Health
NUTX
$1.02B
$249K ﹤0.01%
+2,000
New +$258K
RWL icon
781
Invesco S&P 500 Revenue ETF
RWL
$9.57B
$248K ﹤0.01%
2,380
FITB
782
Fifth Third Bancorp
FITB
$51.7B
$248K ﹤0.01%
6,032
+245
+4% +$9.19K
AZO icon
783
AutoZone
AZO
$50.2B
$248K ﹤0.01%
67
+7
+12% +$25.8K
VRSK icon
784
Verisk Analytics
VRSK
$27.1B
$248K ﹤0.01%
+795
New +$241K
UTHR icon
785
United Therapeutics
UTHR
$26.3B
$247K ﹤0.01%
860
+50
+6% +$14.9K
PGX icon
786
Invesco Preferred ETF
PGX
$3.81B
$246K ﹤0.01%
22,125
-1,893
-8% -$20.9K
VDC icon
787
Vanguard Consumer Staples ETF
VDC
$7.98B
$246K ﹤0.01%
1,123
+3
+0.3% +$658
HPQ icon
788
HP
HPQ
$24.3B
$243K ﹤0.01%
9,929
-984
-9% -$25.1K
M icon
789
Macy's
M
$6.57B
$238K ﹤0.01%
20,407
-147
-0.7% -$1.7K
SBS icon
790
Sabesp
SBS
$19.9B
$235K ﹤0.01%
55,175
GLPI icon
791
Gaming and Leisure Properties
GLPI
$12.8B
$235K ﹤0.01%
5,031
-103
-2% -$4.87K
HCI icon
792
HCI Group
HCI
$2.25B
$234K ﹤0.01%
+1,535
New +$236K
CAH icon
793
Cardinal Health
CAH
$53.7B
$232K ﹤0.01%
+1,378
New +$205K
ITT icon
794
ITT
ITT
$17.7B
$230K ﹤0.01%
+1,469
New +$209K
TEX icon
795
Terex
TEX
$7.89B
$228K ﹤0.01%
+4,890
New +$204K
WTM icon
796
White Mountains Insurance
WTM
$5.43B
$228K ﹤0.01%
127
-50
-28% -$88.9K
MAA icon
797
Mid-America Apartment Communities
MAA
$15.5B
$228K ﹤0.01%
1,540
-10
-0.6% -$1.56K
AIQ icon
798
Global X Artificial Intelligence & Technology ETF
AIQ
$9.26B
$225K ﹤0.01%
+5,155
New +$200K
SNA icon
799
Snap-on
SNA
$21.1B
$225K ﹤0.01%
722
-17
-2% -$5.41K
TV icon
800
Televisa
TV
$1.48B
$224K ﹤0.01%
102,225
-50
-0% -$98

Similar funds

Pinnacle Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Pinnacle Associates held 865 positions worth $6.91B, up 1.2% from $6.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Pinnacle Associates withdrew a net $567M in Q2 2025, closing 20 positions and reducing 470 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pinnacle Associates opened a new position in Evolus worth $6.32M.

  • Pinnacle Associates's largest Q2 2025 buy was Evolus: 685,960 shares worth $6.32M.
  • Pinnacle Associates added most to Vanguard Total Stock Market ETF in Q2 2025, an estimated $34.6M increase.
  • Pinnacle Associates's biggest Q2 2025 reduction was Johnson & Johnson, cutting an estimated $335M.
  • Pinnacle Associates fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $17.9M.
  • Pinnacle Associates's ten largest holdings make up 24% of its $6.91B portfolio in Q2 2025.
  • Pinnacle Associates opened 42 new positions and closed 20 in Q2 2025.
  • Pinnacle Associates's portfolio value rose 1.2% quarter-over-quarter to $6.91B.

Based on Pinnacle Associates's 13F filing for Q2 2025, filed 4 Aug 2025.